Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
797 JPY | +0.50% | +2.05% | -32.00% |
03-21 | US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak | MT |
03-21 | JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion | MT |
Sales 2024 * | 45.37B 286M 391M | Sales 2025 * | 41.75B 264M 360M | Capitalization | 99.47B 628M 858M |
---|---|---|---|---|---|
Net income 2024 * | 7.24B 45.74M 62.52M | Net income 2025 * | 6.28B 39.66M 54.22M | EV / Sales 2024 * | 2.47 x |
Net Debt 2024 * | 12.66B 79.92M 109M | Net Debt 2025 * | 9B 56.79M 77.63M | EV / Sales 2025 * | 2.6 x |
P/E ratio 2024 * |
13.7
x | P/E ratio 2025 * |
15.8
x | Employees | 879 |
Yield 2024 * |
2.46% | Yield 2025 * |
2.51% | Free-Float | 52.97% |
1 day | +0.50% | ||
1 week | +2.05% | ||
Current month | -7.22% | ||
1 month | -8.07% | ||
3 months | -27.87% | ||
6 months | -25.89% | ||
Current year | -32.00% |
Managers | Title | Age | Since |
---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Hiroyuki Sonoda
CTO | Chief Tech/Sci/R&D Officer | 45 | 03-03-31 |
Yutaka Honda
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Toshihide Yoda
BRD | Director/Board Member | 61 | 18-06-26 |
Philippe Fauchet
BRD | Director/Board Member | 65 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.67% | 23 M€ | +1.75% | - | |
0.30% | 15 M€ | +7.34% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 797 | +0.50% | 800,300 |
24-04-25 | 793 | -2.46% | 562,900 |
24-04-24 | 813 | +0.62% | 410,000 |
24-04-23 | 808 | -0.37% | 516,800 |
24-04-22 | 811 | +3.84% | 574,400 |
Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.00% | 632M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 4552 Stock